fever on day 2 and 3 after injection; Left side of mouth drooping; Extremely swollen and painful lymph nodes on left armpit; Neck soreness; Discomfort (left side behind eye); Left eye dryness; pain at injection site the first and second day; Muscle pain in legs, arms; Headache; Extremely swollen and painful lymph nodes on left armpit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Feb2022 13:00 (Lot number: FM0698) at the age of 48 years as dose 2 (tris), single for covid-19 immunisation. Relevant medical history included: "Blood transfusions", start date: 2010 (unspecified if ongoing); "Uterine fibroids" (unspecified if ongoing); "Hysterectomy", start date: 2010 (unspecified if ongoing); "Viral meningitis" (unspecified if ongoing), notes: at age 5 and 11; "Blood clot episode on leg" (unspecified if ongoing), notes: blood clot episode on leg; "Migraines" (unspecified if ongoing); "Sinusit" (unspecified if ongoing). Concomitant medication(s) included: VITAMINE A; VITAMIN E [TOCOPHEROL]; CALCIUM; ZINC; MUCINEX. Past drug history included: Prednisone, reaction(s): "Known allergies: Prednisone", notes: Known allergies: Prednisone; Yasmin, start date: 2008, notes: contraceptive pill in 2008 for about a month but had to stop after a blood clot episode on leg. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FL3198, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 01Feb2022, when the patient was 48 years old, for COVID-19 immunization, reaction(s): "slight pain on the first nigh at injection site". The following information was reported: FACIAL PARALYSIS (medically significant) with onset 22Feb2022 22:00, outcome "not recovered", described as "Left side of mouth drooping"; LYMPH NODE PAIN (non-serious), LYMPHADENOPATHY (non-serious) all with onset 22Feb2022 22:00, outcome "not recovered" and all described as "Extremely swollen and painful lymph nodes on left armpit"; NECK PAIN (non-serious) with onset 22Feb2022 22:00, outcome "not recovered", described as "Neck soreness"; OCULAR DISCOMFORT (non-serious) with onset 22Feb2022 22:00, outcome "not recovered", described as "Discomfort (left side behind eye)"; DRY EYE (non-serious) with onset 22Feb2022 22:00, outcome "not recovered", described as "Left eye dryness"; VACCINATION SITE PAIN (non-serious) with onset 22Feb2022 22:00, outcome "not recovered", described as "pain at injection site the first and second day"; MYALGIA (non-serious) with onset 22Feb2022 22:00, outcome "not recovered", described as "Muscle pain in legs, arms"; HEADACHE (non-serious) with onset 22Feb2022 22:00, outcome "not recovered", described as "Headache"; PYREXIA (non-serious) with onset 24Feb2022, outcome "not recovered", described as "fever on day 2 and 3 after injection". The patient underwent the following laboratory tests and procedures: body temperature: (24Feb2022) unknown result; sars-cov-2 test: (23Feb2022) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of facial paralysis, lymph node pain, neck pain, ocular discomfort, dry eye, vaccination site pain, myalgia, headache, lymphadenopathy, pyrexia. Clinical information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Vitamins B+ was the other medication that the patient received within 2 weeks of vaccination. Prior to the vaccination patient was not diagnosed with COVID-19. Since, the vaccination the patient has been tested for COVID-19. No hospitalization prolonged. Second dose - fever on day 2 and 3 after injection; extremely swollen and painful lymph nodes on left armpit (writing on day 4 and was still not improving), pain at injection site the first and second day; neck soreness, muscle pain in legs, arms; left side of mouth drooping, left eye dryness, headache and discomfort (left side behind eye).   No follow-up attempts are possible. No further information is expected.